TL;DR
This study developed brain-derived neurotrophic factor (BDNF)-loaded PLGA microspheres to improve peripheral nerve regeneration in rats. These microspheres successfully delivered BDNF in a sustained manner, promoting the migration and differentiation of stem cells, and ultimately enhancing nerve function recovery and preventing muscle atrophy.
What Problem Does This Paper Address?
Peripheral nerve injuries, especially those involving long nerve defects, pose a significant challenge in reconstructive surgery. Current treatments like end-to-end anastomosis or autologous nerve grafts have limitations, including insufficient donor sources, donor site morbidity, and slow regeneration rates leading to muscle atrophy and functional deficits. Brain-derived neurotrophic factor (BDNF) is a crucial neurotrophic factor for nerve regeneration, but its direct administration is hampered by poor stability and rapid degradation in the body. This paper addresses the need for a controlled and sustained delivery system for BDNF to effectively promote peripheral nerve repair.
Methods
The researchers employed a multi-faceted approach to develop and evaluate their BDNF-loaded PLGA microspheres:
- Microsphere Fabrication: They used an oil-in-water emulsification-solvent evaporation method to encapsulate BDNF within poly(D,L-lactide-co-glycolide) (PLGA) microspheres.
- Characterization: The microspheres were characterized for their morphology, particle size, encapsulation efficiency, and drug loading capacity using scanning electron microscopy (SEM) and ELISA.
- In Vitro Release Studies: The sustained release profile of BDNF from the microspheres was assessed over 50 days using ELISA.
- Cell Culture Assays: Adipose-derived mesenchymal stem cells (ADSCs) were isolated and cultured. Their proliferation was evaluated using CCK-8 assays, and their migration was assessed using Transwell assays.
- Animal Model: A sciatic nerve defect model was created in Sprague-Dawley rats. The defect was repaired using different treatments: saline (control), PLGA microspheres (blank), BDNF alone, and BDNF-loaded PLGA microspheres.
- Functional Assessment: Nerve function recovery was evaluated using the sciatic functional index (SFI) and neuroelectrophysiological testing (nerve conduction velocity - NCV, and compound muscle action potential - CMAP).
- Histological and Molecular Analysis: Nerve regeneration was assessed through histological evaluation (HE and Toluidine blue staining) and immunofluorescence staining for S-100 and GFAP. RT-qPCR was used to measure the expression of GFAP and S-100.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Sustained BDNF Release: The PLGA microspheres demonstrated a remarkable ability to release BDNF over an extended period (over 50 days), overcoming the short half-life of free BDNF. This sustained release is crucial for continuous support of nerve regeneration.
- Enhanced Stem Cell Activity: BDNF, both in its free form and encapsulated within microspheres, significantly promoted the proliferation and migration of ADSCs. This suggests that the microspheres not only deliver BDNF but also leverage the inherent regenerative potential of stem cells.
- Synergistic Effect of Microspheres: While BDNF alone showed some benefits, the BDNF-loaded PLGA microspheres demonstrated superior outcomes in promoting nerve regeneration, indicating a synergistic effect between the sustained drug delivery and the biological activity of BDNF.
- Improved Nerve Conduction and Structure: The microsphere treatment led to improved nerve conduction velocity and compound amplitude, along with a more organized and uniformly distributed nerve fiber structure, suggesting effective functional and structural recovery.
Key Results
- Microsphere Properties: The BDNF-loaded PLGA microspheres were spherical with uniform particle sizes (46.38 ± 1.00 µm) and exhibited high encapsulation efficiency (>90%) and drug loading capacity.
- In Vitro Release: Cumulative BDNF release reached approximately 30 ng within the first week and continued to be released slowly for over 50 days.
- Cell Proliferation and Migration: BDNF and BDNF microspheres significantly increased ADSC proliferation and migration compared to control groups.
- Nerve Function: In rats, BDNF microspheres significantly improved the sciatic functional index (SFI) compared to control and blank microsphere groups. Neuroelectrophysiological tests showed that BDNF microspheres significantly decreased nerve conduction velocity (NCV) and compound amplitude (AMP) compared to control, indicating improved nerve function.
- Histology: Histological evaluation revealed increased numbers of myelinated nerve fibers with regular morphology in the BDNF microsphere group. Immunofluorescence showed significantly higher expression of S-100 and GFAP in the BDNF and BDNF microsphere groups, indicating enhanced nerve tissue formation.
- Muscle Weight: BDNF and BDNF microspheres significantly increased the wet weight ratio of the gastrocnemius muscle, suggesting prevention of muscle atrophy.
Limitations and Future Work
The authors acknowledge several limitations:
- PLGA Degradation: The in vivo degradation rate of the PLGA microspheres remains unclear.
- Downstream Signaling: The specific downstream signaling pathways modulated by BDNF are not fully elucidated.
- Long-Term Effects: The long-term effects of BDNF microsphere treatment for nerve damage repair are yet to be established.
- Translation to Humans: This study was conducted in rats, and further research is needed to translate these findings to larger animals and eventually to human clinical applications.
Future work should focus on addressing these limitations, including investigating the degradation kinetics, exploring the molecular mechanisms, and conducting preclinical trials in larger animal models to pave the way for clinical translation.
Summary updated